CoChat

The SAGE study: Global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DM

Open access
Renard, Eric, Ikegami, Hiroshi, Daher Vianna, André Gustavo, Pozzilli, Paolo, Brette, Sandrine, Bosnyak, Zsolt, Lauand, Felipe, Peters, Anne, Pilorget, Valerie, Jurišić‐Eržen, Dubravka, Kesavadev, Jothydev, Seufert, Jochen, Wilmot, Emma G. · 2021 · Diabetes/Metabolism Research and Reviews
Cited by 77

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Aims: To describe glycaemic control and diabetes management in adults with type 1 diabetes (T1DM), in a real‐life global setting. Materials and Methods: Study of Adults' GlycEmia (SAGE) was a multinational, multicentre, single visit, noninterventional, cross‐sectional study in adult patients with T1DM. Data were collected at a single visit, analysed according to predefined age groups (26–44, 45–64 and ≥65 years) and reported across different regions. The primary endpoint was the proportion of participants achieving HbA 1c less than 7.0 % in each age group. Secondary endpoints included incidence of hypoglycaemia, severe hypoglycaemia and severe hyperglycaemia leading to diabetic ketoacidosis (DKA) and therapeutic management of T1DM. Results: Of 3903 included participants, 3858 (98.8%) were eligible for the study. Overall, 24.3% (95% confidence interval [CI]: 22.9–25.6) of participants achieved the glycaemic target of HbA 1c less than 7.0 %, with more participants achieving this target in the 26–44 years group (27.6% [95% CI: 25.5–29.8]). Target achievement was highest in Eastern and Western Europe, and lowest in the Middle East. The incidence of hypoglycaemia and of severe hyperglycaemia leading to DKA tended to decrease with age, and varied across regions. Age and regional differences were observed in therapeutic management, including types of device/insulin usage, frequency of insulin dose adjustment and technology usage. Conclusions: Glycaemic control remains poor in adults with T1DM globally. Several areas of treatment may be optimised to improve outcomes, including supporting patient self‐management of insulin therapy, increasing use of technologies such as CGM, and greater provision of healthcare support.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/dmrr.3430

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 77

Metadata

Authors
Renard, E., Ikegami, H., Daher Vianna, A. G., Pozzilli, P., Brette, S., Bosnyak, Z., Lauand, F., Peters, A., Pilorget, V., Jurišić‐Eržen, D., Kesavadev, J., Seufert, J., & Wilmot, E. G.
Venue
Diabetes/Metabolism Research and Reviews
Publisher
Wiley
Published
2021-03-02
Volume
37
Issue
7
Pages
e3430-e3430
ISSN
  • 1520-7552 (ISSN-L)
  • 1520-7560
OpenAlex
W3116343197
Cited by
77
References
7
FWCI
7.01
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The SAGE study: Global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DM. https://app.cochat.ai/papers/10.1002/dmrr.3430
The paper
Renard, E., Ikegami, H., Daher Vianna, A. G., Pozzilli, P., Brette, S., Bosnyak, Z., Lauand, F., Peters, A., Pilorget, V., Jurišić‐Eržen, D., Kesavadev, J., Seufert, J., & Wilmot, E. G. (2021). The SAGE study: Global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DM. Diabetes/Metabolism Research and Reviews. https://doi.org/10.1002/dmrr.3430

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.